Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 6Unknown 3Terminated 2Recruiting 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Retinoblastoma 1Retinal Neoplasms 1Breast Neoplasms 1Atrophy 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Lasers × Clear all
NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting
133 enrolled
Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

NCT04081805 2025-04-24

EPMLARF

Federal University of São Paulo

Phase NA Active not recruiting
195 enrolled
Breast

Atrophy, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡